Literature DB >> 8005305

Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage.

J Donnez1, M Nisolle, S Gillerot, V Anaf, F Clerckx-Braun, F Casanas-Roux.   

Abstract

OBJECTIVE: To evaluate the role of GnRH agonist (GnRH-a) and/or drainage in the management of large endometriomas.
DESIGN: This prospective clinical study was conducted in a parallel and randomized design.
SETTING: Department of Gynecology, Cliniques Universitaires St. Luc, Brussels, Belgium. PATIENTS: Eight infertile women with laparoscopically confirmed ovarian endometriotic cysts. After laparoscopic drainage of the ovarian cyst, patients were randomized. Patients in group I (n = 40) received no therapy. Patients in group II (n = 40) received GnRH-a therapy for 12 weeks. A second-look laparoscopy was performed after 12 weeks in each woman.
RESULTS: After drainage, a quick recurrence of the endometrial cyst was observed in only group I. Indeed, the score and the cyst size were similar to the values observed before the first laparoscopy. In group II, a significant decrease in score and cyst diameter was observed. Ovarian biopsies revealed significant reduction in the stromal vascularization and a significant reduction in the mitotic activity in the group of women treated with GnRH-a.
CONCLUSION: The quick recurrence of the ovarian cyst after drainage proved that drainage alone is ineffective. Drainage followed by GnRH-a was effective in the reduction of cyst size and the glandular mitotic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005305     DOI: 10.1016/s0015-0282(16)56816-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Late manifestation of pelvic abscess following oocyte retrieval, for in vitro fertilization, in patients with severe endometriosis and ovarian endometriomata.

Authors:  J S Younis; Y Ezra; N Laufer; G Ohel
Journal:  J Assist Reprod Genet       Date:  1997-07       Impact factor: 3.412

2.  The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice.

Authors:  Mahaut Leconte; Carole Nicco; Charlotte Ngô; Christiane Chéreau; Sandrine Chouzenoux; Wioleta Marut; Jean Guibourdenche; Sylviane Arkwright; Bernard Weill; Charles Chapron; Bertrand Dousset; Frédéric Batteux
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

Review 3.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

Review 4.  Pre and post operative medical therapy for endometriosis surgery.

Authors:  C Yap; S Furness; C Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2004

5.  Pre- and postsurgical medical therapy for endometriosis surgery.

Authors:  Innie Chen; Veerle B Veth; Abdul J Choudhry; Ally Murji; Andrew Zakhari; Amanda Y Black; Carmina Agarpao; Jacques Wm Maas
Journal:  Cochrane Database Syst Rev       Date:  2020-11-18

6.  Effect of Surgical Removal of Endometriomas on Cyclic and Non-cyclic Pelvic Pain.

Authors:  Murat Api; Aysen Telce Boza; Semra Kayatas; Mustafa Eroglu
Journal:  Int J Fertil Steril       Date:  2015-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.